Floatz logo

su011248

Chronic Neutrophilic Leukemia

National Cancer Institute (NCI)Phase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Chronic Neutrophilic Leukemia cohort.

Asset / SponsorPhaseRating
CALCIUM PHOSPHATE
Children's Oncology Group
Phase 3BB
TACROLIMUS
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2B
PROPADERM FORTE
Fred Hutchinson Cancer Center
Phase 2B
Busulphan
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2B
Romidepsin
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2B

View all 33 →

Same molecule, other indications

su011248 is also rated in:

Gastrointestinal Stromal TumorsDormant
BBB
Indicative ·
75 / 100
View asset →
Pancreatic Neuroendocrine TumorDormant
BB
Indicative ·
69 / 100
View asset →
Renal Cell CarcinomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →